Abbott just announced a “medical device correction” for approximately three million glucose sensor monitors in the U.S., ...
Medical Device Network on MSN
Abbott issues correction over incorrect FreeStyle Libre sensor readings
The correction relates to around three million sensors used in Abbott’s FreeStyle Libre 3 and Libre 3 Plus CGMs in the US.
Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors ...
The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.
Abbott Laboratories said on Monday it has begun a correction in the United States for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring sensors after internal testing showed some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback